Wells Fargo Maintains Equal-Weight on GoodRx Holdings, Raises Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stan Berenshteyn maintains an Equal-Weight rating on GoodRx Holdings (NASDAQ:GDRX) and raises the price target from $6 to $7.
August 10, 2023 | 11:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo maintains an Equal-Weight rating on GoodRx Holdings and raises the price target from $6 to $7.
The raised price target by Wells Fargo indicates a positive outlook for GoodRx Holdings. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100